BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 377082)

  • 1. Choline in Alzheimer's disease.
    Renvoize EB; Jerram T
    N Engl J Med; 1979 Aug; 301(6):330. PubMed ID: 377082
    [No Abstract]   [Full Text] [Related]  

  • 2. Choline bitartrate treatment of Alzheimer-type dementias.
    Fovall P; Dysken MW; Lazarus LW; Davis JM; Kahn RL; Jope R; Finkel S; Rattan P
    Commun Psychopharmacol; 1980; 4(2):141-5. PubMed ID: 7428335
    [No Abstract]   [Full Text] [Related]  

  • 3. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 5. Choline therapy in Alzheimer's disease.
    Smith CM; Swash M; Exton-Smith AN; Phillips MJ; Overstall PW; Piper ME; Bailey MR
    Lancet; 1978 Aug; 2(8084):318. PubMed ID: 79110
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of choline on amnesia in early Alzheimer's disease.
    Signoret JL; Whiteley A; Lhermitte F
    Lancet; 1978 Oct; 2(8094):837. PubMed ID: 81385
    [No Abstract]   [Full Text] [Related]  

  • 8. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline chloride in Alzheimer disease.
    Thal LJ; Rosen W; Sharpless NS; Crystal H
    Ann Neurol; 1981 Dec; 10(6):580. PubMed ID: 7325608
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of naloxone in senile dementia: a double-blind trial.
    Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E
    N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389
    [No Abstract]   [Full Text] [Related]  

  • 13. Double blind study of lecithin in patients with Alzheimer's disease.
    Fisman M; Merskey H; Helmes E; McCready J; Colhoun EH; Rylett BJ
    Can J Psychiatry; 1981 Oct; 26(6):426-8. PubMed ID: 7028239
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls.
    Sunderland T; Tariot PN; Mueller EA; Murphy DL; Weingartner H; Cohen RM
    Psychopharmacol Bull; 1985; 21(3):676-9. PubMed ID: 3898182
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurochemical approaches to the treatment of senile dementia.
    Growdon JH; Corkin S
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of choline on amnesia in Alzheimer's disease (author's transl)].
    Whiteley A; Signoret JL; Agid Y; Lhermitte F
    Rev Neurol (Paris); 1979 Oct; 135(8-9):565-72. PubMed ID: 531411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research design issues: antialuminum drug studies in Alzheimer's disease.
    Shore D; Wyatt RJ
    Clin Neuropharmacol; 1982 Dec; 5(4):337-43. PubMed ID: 7159877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of choline in Alzheimer's disease.
    Etienne P; Gauthier S; Johnson G; Collier B; Mendis T; Dastoor D; Cole M; Muller HF
    Lancet; 1978 Mar; 1(8062):508-9. PubMed ID: 76060
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease.
    Cutler NR; Haxby JV; Narang PK; May C; Burg C; Reines SA
    N Engl J Med; 1985 Mar; 312(11):725. PubMed ID: 2858052
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.